prostate cancer

People at high risk for psychological distress respond positively to receiving results of personalized genetic testing, according to new research at Washington University School of Medicine in St. Louis. More than 60 percent of subjects in the genetic study wanted information about their test results, and 95 percent said they appreciated receiving the information, regardless of whether the results were good or bad news.

Prostate biopsies performed using magnetic resonance imaging are more likely to find aggressive tumors than those that rely on ultrasound, suggests a new study led by Gerald Andriole, MD, chief of urology at the School of Medicine.

Gerald Andriole, MD, chief of urologic surgery at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is a co-author of new research showing that many men with prostate cancer do not need immediate treatment, especially if they have low PSA scores or low-risk tumors that are unlikely to grow and spread.

A new study shows that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions. The study was published online Jan. 6 in the Journal of the National Cancer Institute.

High-dose vitamin E supplements increase the risk of prostate cancer, results of a large clinical trial show. The study’s findings, published Oct. 12, 2011, in the Journal of the American Medical Association, are based on an updated review of data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

The typical American diet includes nearly twice the recommended daily allowance for protein, and now a team of nutrition researchers, including Luigi Fontana, MD, PhD, and urologic surgeons at the School of Medicine, is conducting two studies to investigate a potential link between cancer and excess protein in the diet.  

A new study by Gerald Andriole, MD, chief of urologic surgery at Washington University School of Medicine in St. Louis, suggests the PSA test is more reliable in men taking dutasteride (Avodart®), a drug widely prescribed to shrink an enlarged prostate gland. Even a slight rise in PSA levels among men taking the drug was a stronger indicator of cancer than rising PSA levels in men taking a dummy pill.

Adam Kibel has been named the Holekamp Family Chair in Urology at Barnes-Jewish Hospital and Washington University School of Medicine. The endowed chair was established by Bill and Kerry Holekamp and the Holekamp Family Foundation through the Barnes-Jewish Hospital Foundation.

R. Sherburne Figenshau, M.D., has been named the Taylor Family and Ralph V. Clayman, M.D., Minimally Invasive Urology Chair at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

Gerald L. Andriole Jr. has been named the inaugural Robert Killian Royce Distinguished Professor in Urologic Surgery at the School of Medicine.